Skip to main content

Table 1 Demographic, clinical features, motor, and sensory level changes of the patients

From: Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes

Patient number

Sex

Age (years)

Cause of injury

LOI

Interval between injection and trauma (months)

Motor level pre-treatment

Motor level 6 months after treatment

Motor level 12 months after treatment

Sensory level pre-treatment

Sensory level 6 months after treatment

Sensory level 12 months after treatment

1

Male

18

Accident

C4

3

C7

C7

C8

T4

T4

T4

2

Female

42

Accident

T3

7

T1

T1

T1

T3

T4

T4

3

Female

38

Accident

T10

3.5

L1

L1

L1

L1

L1

L1

4

Male

27

Accident

C5

5

C6

C7

C7

C5

C5

C5

5

Male

21

Accident

T12

9

T1

L3

L3

L5

L5

L5

6

Male

30

Accident

T6

5.5

T1

T1

T1

T8

T10

T10

7

Male

17

Falling

T5

3

T1

T1

T1

T5

T9

T9

8

Male

30

Accident

C5

4

C7

C7

C7

T2

T3

T3

9

Male

19

Accident

T2

7

T1

T1

-

T3

T3

T12

10

Male

40

Accident

T11

3

T1

T1

-

T12

T12

-

11

Male

38

Accident

C5

8

C7

C8

C8

C4

C4

C4

  1. LOI level of injury